Skip to main content
logo
Gennex Laboratories Limited (BOM:531739)
India flag India · Delayed Price · Currency is INR
11.22
+0.48 (4.47%)
At close: Mar 5, 2026

Gennex Laboratories Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
181.23131.7549.2139.2340.38
Depreciation & Amortization
19.9123.689.197.888.81
Other Operating Activities
-59.0625.981.4520.21.8
Change in Accounts Receivable
36.5-83.9518.97-23.67-26.67
Change in Inventory
-107.65-94.83-79.56-27.1824.19
Change in Accounts Payable
-20.2120.5124.4654.74-39.32
Change in Other Net Operating Assets
-158.68-490113.0447.88-23.56
Operating Cash Flow
-107.97-466.86236.76119.08-14.37
Operating Cash Flow Growth
--98.82%--
Capital Expenditures
-89.47--397.86-15.94-0.79
Sale of Property, Plant & Equipment
2153.530.50.29-
Investment in Securities
--2.34-12.54--
Other Investing Activities
95.7137.9526.61-90.54
Investing Cash Flow
8.24189.13-383.29-24.66-0.25
Short-Term Debt Issued
44.98--27.6223.78
Long-Term Debt Issued
36.77-10.18--
Total Debt Issued
81.75-10.1827.6223.78
Short-Term Debt Repaid
---90.7--
Long-Term Debt Repaid
--30.72--37.15-0.15
Total Debt Repaid
--30.72-90.7-37.15-0.15
Net Debt Issued (Repaid)
81.75-30.72-80.52-9.5423.62
Issuance of Common Stock
-798.32304.39--
Other Financing Activities
-36.08-30.76-13.54-8.77-7.44
Financing Cash Flow
45.67736.84210.33-18.3116.19
Miscellaneous Cash Flow Adjustments
0----
Net Cash Flow
-54.06459.1163.8176.111.57
Free Cash Flow
-197.44-466.86-161.1103.14-15.16
Free Cash Flow Margin
-14.32%-53.84%-24.56%16.85%-2.54%
Free Cash Flow Per Share
-0.85-2.15-1.040.81-0.12
Cash Interest Paid
36.0830.7613.548.777.44
Cash Income Tax Paid
32.2--11.115.34
Levered Free Cash Flow
-250.11-511.57-175.8417.82-30
Unlevered Free Cash Flow
-227.56-492.34-167.3823.3-25.35
Change in Working Capital
-250.04-648.27176.9151.77-65.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.